Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy

NCT ID: NCT03575286

Last Updated: 2018-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

123 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-28

Study Completion Date

2019-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this observational study is to demonstrate the feasibility of an automated point-of-care urine diagnostic device in determining the pregnancy status of patients through urine samples collected from patients at Northwestern University. Our hypothesis is that this automated point-of-care urine diagnostic device will be able to accurately determine a patient's pregnancy status at least 95% of the time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant female

Patient has been determined pregnant with a urine pregnancy test and, if applicable, a serum pregnancy test performed at Northwestern University.

Pregnancy test

Intervention Type DIAGNOSTIC_TEST

Detects hormone (hCG, Human Chorionic Gonadotropin) produced by the body during pregnancy

Non-pregnant female

Patient has been determined not pregnant with a urine pregnancy test and, if applicable, a serum pregnancy test performed at Northwestern University.

Pregnancy test

Intervention Type DIAGNOSTIC_TEST

Detects hormone (hCG, Human Chorionic Gonadotropin) produced by the body during pregnancy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pregnancy test

Detects hormone (hCG, Human Chorionic Gonadotropin) produced by the body during pregnancy

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient age 18 years and older, upper age limit of 45 years
* Female patient
* Patients undergoing any procedures for pregnancy diagnosis and confirmation
* English speaking

The following special population will be included:

* Pregnant women

Exclusion Criteria

* Adults unable to consent
* Individuals who are not yet adults (infants, children, and teenagers)
* Prisoners
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University

OTHER

Sponsor Role collaborator

Voyant Diagnostics, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MaryEllen Pavone, MD, MSCI

Role: PRINCIPAL_INVESTIGATOR

Northwestern University, Department of Obstetrics and Gynecology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northwestern University

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael Tu, MS, BS

Role: CONTACT

214-415-4288

Claire Y Zhou, BA

Role: CONTACT

949-355-3695

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

MaryEllen Pavone, MD, MSCI

Role: primary

312-926-8244

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Early PrEgnancy Complications Testing
NCT04079361 RECRUITING NA
Covid-19 Infection in Pregnancy
NCT04869202 COMPLETED